Skip to main content
Top
Published in: Rheumatology International 9/2014

01-09-2014 | Letter to the Editor

Predictive role of neutrophil to lymphocyte ratio in Henoch–Schonlein purpura related gastrointestinal bleeding

Authors: Alpaslan Tanoglu, Ergenekon Karagoz

Published in: Rheumatology International | Issue 9/2014

Login to get access

Abstract

We read with interest the recent article ‘The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch–Schonlein purpura’ by Makay et al. (Rheumatol Int. doi:10.​1007/​s00296-014-2986-2, 2014). In their study, researchers aimed to evaluate the relationship between blood neutrophil to lymphocyte ratio (NLR) and gastrointestinal bleeding in children with Henoch–Schonlein purpura (HSP). In discussion part, the authors concluded that blood NLR may be considered as a useful marker for predicting gastrointestinal bleeding in HSP. We would like to thank Makay et al. for their valuable contribution.
Literature
1.
go back to reference Makay B, Gücenmez OA, Duman M, Unsal E (2014) The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch–Schonlein purpura. Rheumatol Int. doi:10.1007/s00296-014-2986-2 Makay B, Gücenmez OA, Duman M, Unsal E (2014) The relationship of neutrophil-to-lymphocyte ratio with gastrointestinal bleeding in Henoch–Schonlein purpura. Rheumatol Int. doi:10.​1007/​s00296-014-2986-2
2.
go back to reference Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L et al (2012) Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int 32:297–302PubMedCrossRef Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L et al (2012) Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease. Liver Int 32:297–302PubMedCrossRef
3.
go back to reference Tanoglu A, Karagoz E (2014) Predictive role of the neutrophil-to-lymphocyte ratio in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev 15:1063PubMedCrossRef Tanoglu A, Karagoz E (2014) Predictive role of the neutrophil-to-lymphocyte ratio in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev 15:1063PubMedCrossRef
4.
go back to reference Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL et al (2013) Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109:416–421PubMedCentralPubMedCrossRef Stotz M, Gerger A, Eisner F, Szkandera J, Loibner H, Ress AL et al (2013) Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer 109:416–421PubMedCentralPubMedCrossRef
5.
go back to reference Karaman M, Balta S, Ay SA, Cakar M, Naharci I, Demirkol S et al (2013) The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens 35:516–522PubMedCrossRef Karaman M, Balta S, Ay SA, Cakar M, Naharci I, Demirkol S et al (2013) The comparative effects of valsartan and amlodipine on vWf levels and N/L ratio in patients with newly diagnosed hypertension. Clin Exp Hypertens 35:516–522PubMedCrossRef
Metadata
Title
Predictive role of neutrophil to lymphocyte ratio in Henoch–Schonlein purpura related gastrointestinal bleeding
Authors
Alpaslan Tanoglu
Ergenekon Karagoz
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 9/2014
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3028-9

Other articles of this Issue 9/2014

Rheumatology International 9/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.